logo-loader
viewFeedback PLC

Feedback PLC - Director/PDMR Shareholding

RNS Number : 1059R
Feedback PLC
25 June 2020
 

Feedback plc

 

Director / PDMR Shareholding

 

London, 25 June 2020: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces that it has been informed today that over 17 June 2020 and 18 June 2020, Adam Denning, Non-Executive of the Company, purchased a total of 1,530,411 ordinary shares of 0.25p each in the Company ("Ordinary Share") at an average price of 0.9762 pence per share.

 

Following these purchases, Adam Denning holds 1,530,411 Ordinary Shares, representing 0.28 per cent. of the Company's issued share capital as at the date of this announcement.

 

The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation, is appended below.

 

 

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

[email protected]



Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

+44 (0)20 3328 5656



Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey

+44 (0)20 7469 0936



Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

+44 20 3815 8880



Instinctif Partners

Melanie Toyne-Sewell / Phillip Marriage

+44 (0)20 7457 2020

+44 7890 022 814

[email protected]

 

 

Notes to editors

 

About Feedback plc - www.fbk.com

 

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited.  Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

 

Feedback has launched Bleepa, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS).  For more information on Bleepa, see www.bleepa.com.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.  

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adam Denning

2

Reason for the notification

a)

Position/status

Non-Executive Director

b) 

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Feedback plc

b)

LEI

213800UGOF2GT2U2RV90

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 0.25p each

 

Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550 

b)

Nature of the transaction

Purchase of Ordinary Shares 

c)

Price(s) and volume(s)

Date

 Price(s)

Volume(s)

17 June 2020

 

 

 

18 June 2020

0.9733p

0.9949p

0.9733p

0.9699p

0.9679p

 

409,745

300,336

409,745

101,871

308,714

 

d)

Aggregated information

 

- Aggregated volume

- Price

 

 

 

1,530,411 Ordinary Shares

0.9762p

 

 

e)

Date of the transaction

17 and 18 June 2020

f)

Place of the transaction

London Stock Exchange, XLON

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHPPUAAQUPUGUA

Quick facts: Feedback PLC

Price: 1.2

Market: LSE
Market Cap: £12.8 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Feedback's Tom Oakley says inclusion of Bleepa to major framework is big...

Feedback PLC's (LON:FDBK) Tom Oakley speaks to Proactive's Polly Middlehurst following the news its flagship imaging-based communication platform Bleepa has been awarded a place on the NHSx National Clinical Communication Tool (NCCT) framework. ''For Bleepa this isn't just a great opportunity...

1 week, 6 days ago